These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17466438)

  • 1. Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor.
    Kroe RR; Baker MA; Brown MP; Farrow NA; Gautschi E; Hopkins JL; LaFrance RR; Kronkaitis A; Freeman D; Thomson D; Nabozny G; Grygon CA; Labadia ME
    Biophys Chem; 2007 Jul; 128(2-3):156-64. PubMed ID: 17466438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.
    Schoch GA; D'Arcy B; Stihle M; Burger D; Bär D; Benz J; Thoma R; Ruf A
    J Mol Biol; 2010 Jan; 395(3):568-77. PubMed ID: 19913032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical probes to identify the glucocorticoid receptor ligands in living cells.
    Awais M; Sato M; Umezawa Y
    Steroids; 2007 Dec; 72(14):949-54. PubMed ID: 17897691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry.
    Frego L; Davidson W
    Protein Sci; 2006 Apr; 15(4):722-30. PubMed ID: 16600964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the molecular basis of action of the passive antiglucocorticoid 21-hydroxy-6,19-epoxyprogesterone.
    Alvarez LD; Martí MA; Veleiro AS; Presman DM; Estrin DA; Pecci A; Burton G
    J Med Chem; 2008 Mar; 51(5):1352-60. PubMed ID: 18284186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
    Cho S; Blackford JA; Simons SS
    Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.
    Yoshikawa N; Nagasaki M; Sano M; Tokudome S; Ueno K; Shimizu N; Imoto S; Miyano S; Suematsu M; Fukuda K; Morimoto C; Tanaka H
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1363-73. PubMed ID: 19293335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts.
    Rogatsky I; Luecke HF; Leitman DC; Yamamoto KR
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16701-6. PubMed ID: 12481024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bag-1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors.
    Hong W; Baniahmad A; Li J; Chang C; Gao W; Liu Y
    FEBS Lett; 2009 Aug; 583(15):2451-6. PubMed ID: 19595997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.
    Yoshikawa N; Yamamoto K; Shimizu N; Yamada S; Morimoto C; Tanaka H
    Mol Endocrinol; 2005 May; 19(5):1110-24. PubMed ID: 15677712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression.
    Zhao Q; Pang J; Favata MF; Trzaskos JM
    Int Immunopharmacol; 2003 Dec; 3(13-14):1803-17. PubMed ID: 14636830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
    McMaster A; Ray DW
    Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucocorticoid receptor is a co-regulator of the orphan nuclear receptor Nurr1.
    Carpentier R; Sacchetti P; Ségard P; Staels B; Lefebvre P
    J Neurochem; 2008 Feb; 104(3):777-89. PubMed ID: 17986226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H; Berger M; Rehwinkel H; Asadullah K
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values.
    Zhang S; Jonklaas J; Danielsen M
    Steroids; 2007 Jun; 72(6-7):600-8. PubMed ID: 17509631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
    Newton R; Holden NS
    Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of selective nuclear receptor modulator-induced conformational changes in the nuclear receptor to allow interaction with coactivator and corepressor proteins in living cells.
    Awais M; Sato M; Umezawa Y
    Chembiochem; 2007 May; 8(7):737-43. PubMed ID: 17387660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.